Sinew Pharma Inc. (TPEX:6634)
60.00
0.00 (0.00%)
Aug 19, 2026, 9:52 AM CST
Sinew Pharma Revenue
Sinew Pharma had revenue of 47.00K TWD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 47.00K. In the year 2025, Sinew Pharma had annual revenue of 47.00K.
Revenue
47.00K
Revenue Growth
n/a
P/S Ratio
91,007.14
Revenue / Employee
n/a
Employees
57
Market Cap
4.28B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 328.00K | -5.90M | -94.73% |
| Dec 31, 2021 | 6.23M | 5.77M | 1,248.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Medigen Biotechnology | 1.34B |
| SYN-TECH Chem. & Pharm. | 1.27B |
| Mycenax Biotech | 815.34M |
| Sagittarius Life Science | 392.26M |
| Pharmosa Biopharm | 69.06M |
| Formosa Pharmaceuticals | 52.59M |
| OBI Pharma | 49.68M |
| UnicoCell Biomed | 22.46M |